tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CALT Stock Latest News

Calliditas Therapeutics’ Setanaxib Study: A Potential Game-Changer for Alport Syndrome
Company AnnouncementsCalliditas Therapeutics’ Setanaxib Study: A Potential Game-Changer for Alport Syndrome
6M ago
CALT
Calliditas Therapeutics Completes Key Study on Setanaxib for Alport Syndrome
PremiumCompany Announcements
Calliditas Therapeutics Completes Key Study on Setanaxib for Alport Syndrome
6M ago
CALT
Calliditas Therapeutics Completes Promising Study on Setanaxib for Alport Syndrome
PremiumCompany Announcements
Calliditas Therapeutics Completes Promising Study on Setanaxib for Alport Syndrome
7M ago
CALT
Calliditas Therapeutics’ Setanaxib Study: A New Hope for Alport Syndrome
PremiumCompany Announcements
Calliditas Therapeutics’ Setanaxib Study: A New Hope for Alport Syndrome
7M ago
CALT
Calliditas Therapeutics’ Extended TARPEYO® Study: A Potential Game-Changer in IgA Nephropathy Treatment
PremiumCompany Announcements
Calliditas Therapeutics’ Extended TARPEYO® Study: A Potential Game-Changer in IgA Nephropathy Treatment
8M ago
CALT
CALT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCALT Upcoming Earnings Report: What to Expect?
1y ago
CALT
Calliditas Therapeutics Sets Delisting Process
Premium
Company Announcements
Calliditas Therapeutics Sets Delisting Process
1y ago
6K
CALT
Calliditas Therapeutics to apply for delisting of common shares, ADSs
Premium
The Fly
Calliditas Therapeutics to apply for delisting of common shares, ADSs
1y ago
CALT
Calliditas Therapeutics Sees Strong Sales Growth
PremiumCompany Announcements
Calliditas Therapeutics Sees Strong Sales Growth
2y ago
6K
CALT
CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2y ago
CALT
Calliditas Therapeutics’ Share Capital and Votes Increase
PremiumCompany Announcements
Calliditas Therapeutics’ Share Capital and Votes Increase
2y ago
6K
CALT
Calliditas’ Setanaxib Shows Promise in PBC Trial
PremiumCompany Announcements
Calliditas’ Setanaxib Shows Promise in PBC Trial
2y ago
6K
CALT
Calliditas announces partner approval, EUR 10M milestone payment
PremiumThe FlyCalliditas announces partner approval, EUR 10M milestone payment
2y ago
CALT
Calliditas Therapeutics announces TRANSFORM trial met primary endpoint
Premium
The Fly
Calliditas Therapeutics announces TRANSFORM trial met primary endpoint
2y ago
CALT
Calliditas says partner initiated Phase III Nefecon trial in Japan
Premium
The Fly
Calliditas says partner initiated Phase III Nefecon trial in Japan
2y ago
CALT
Calliditas Therapeutics announces USPTO issues patent for setanaxib
PremiumThe Fly
Calliditas Therapeutics announces USPTO issues patent for setanaxib
2y ago
CALT
Calliditas Therapeutics’ Annual Meeting Highlights
PremiumCompany Announcements
Calliditas Therapeutics’ Annual Meeting Highlights
2y ago
6K
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Pareto
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at Pareto
2y ago
CALT
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
2y ago
CALT
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
PremiumThe FlyWynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
2y ago
O
BZH
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
Premium
The Fly
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
2y ago
CALT
CHMP Endorses Calliditas’ Kinpeygo for IgAN
Premium
Company Announcements
CHMP Endorses Calliditas’ Kinpeygo for IgAN
2y ago
6K
CALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >